SCHEMBL25914560

SCHEMBL25914560

CCc1ccc2c(c1)C(C)NC2=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK2 Q9HBH9 3/20 0.44
MKNK1 Q9BUB5 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 2/20 0.43
NPC1 O15118 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
RAB9A P51151 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
BRD4 O60885 1/20 0.37
HTR2A P28223 5/20 0.35
HTR2C P28335 5/20 0.35
HTR2B P41595 5/20 0.35
IGF1R P08069 1/20 0.35
PIM1 P11309 1/20 0.35
PIM2 Q9P1W9 1/20 0.35
DAO P14920 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23997233 0.86 ALDH1A1 (0.43) MKNK2MKNK1SMN1; SMN2ALDH1A1NPC1
SCHEMBL29978011 0.77 ALDH1A1 (0.47) MKNK2MKNK1ALDH1A1NPC1LMNA
SCHEMBL28387305 0.77 ALDH1A1 (0.47) MKNK2MKNK1ALDH1A1NPC1LMNA
SCHEMBL25317459 0.77 MKNK2 (0.47) MKNK2MKNK1SMN1; SMN2ALDH1A1NPC1
SCHEMBL11188454 0.75 CYP1A2 (0.46) SMN1; SMN2ALDH1A1NPC1LMNAMAPT
SCHEMBL14991575 0.75 MKNK2 (0.46) MKNK2MKNK1MAPTMEN1KMT2A
SCHEMBL20529362 0.75 MKNK2 (0.46) MKNK2MKNK1MAPTHTR2AHTR2C
SCHEMBL18786964 0.75 MKNK2 (0.46) MKNK2MKNK1KMT2A
SCHEMBL13756884 0.74 HTR2A (0.62) HTR2AHTR2CHTR2B
SCHEMBL8157312 0.73 CNR1 (0.43) MKNK2MKNK1SMN1; SMN2HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023139379-A1 MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE (ROCK) REDX PHARMA PLC (GB) 2023-07-27 WO disclosed